MedPath

恒昌(广州)新药研究有限公司

Ownership
-
Established
2018-11-07
Employees
-
Market Cap
-
Website
www.hcnpr.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

30

NMPA:30

Drug Approvals

Sildenafil Citrate Orodispersible Tablets

Product Name
枸橼酸西地那非口崩片
Approval Number
国药准字H20254049
Approval Date
Apr 30, 2025
NMPA

Aspirin Enteric-coated Tablets

Product Name
阿司匹林肠溶片
Approval Number
国药准字H20253994
Approval Date
Apr 22, 2025
NMPA

Acarbose Tablets

Product Name
阿卡波糖片
Approval Number
国药准字H20253463
Approval Date
Feb 25, 2025
NMPA

Montelukast Sodium Chewable Tablets

Product Name
孟鲁司特钠咀嚼片
Approval Number
国药准字H20253341
Approval Date
Feb 8, 2025
NMPA

Montelukast Sodium Chewable Tablets

Product Name
孟鲁司特钠咀嚼片
Approval Number
国药准字H20253342
Approval Date
Feb 8, 2025
NMPA

Desloratadine Oral Solution

Product Name
地氯雷他定口服溶液
Approval Number
国药准字H20234085
Approval Date
Sep 5, 2023
NMPA

Fluoxetine Hydrochloride Dispersible Tablets

Product Name
盐酸氟西汀分散片
Approval Number
国药准字H20233241
Approval Date
Feb 28, 2023
NMPA

Metoprolol Tartrate Tablets

Product Name
酒石酸美托洛尔片
Approval Number
国药准字H20213907
Approval Date
Nov 30, 2021
NMPA

Captopril Tablets

Product Name
卡托普利片
Approval Number
国药准字H44022626
Approval Date
Jul 30, 2021
NMPA

Acetylspiramycin Tablets

Product Name
乙酰螺旋霉素片
Approval Number
国药准字H44022632
Approval Date
Jul 30, 2021
NMPA
  • Prev
  • 1
  • 2
  • 3
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.